Pathfinder Cell Therapy (Pathfinder Cell Therapy) Short-Term Debt : $5.41 Mil (As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Short-Term Debt?

Pathfinder Cell Therapy's Short-Term Debt for the quarter that ended in Sep. 2015 was $5.41 Mil.

Pathfinder Cell Therapy's quarterly Short-Term Debt increased from Mar. 2015 ($5.15 Mil) to Jun. 2015 ($5.23 Mil) and increased from Jun. 2015 ($5.23 Mil) to Sep. 2015 ($5.41 Mil).

Pathfinder Cell Therapy's annual Short-Term Debt increased from Dec. 2012 ($2.25 Mil) to Dec. 2013 ($3.99 Mil) and increased from Dec. 2013 ($3.99 Mil) to Dec. 2014 ($4.98 Mil).

Pathfinder Cell Therapy Short-Term Debt Historical Data

The historical data trend for Pathfinder Cell Therapy's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Short-Term Debt Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Short-Term Debt

Get a 7-Day Free Trial

0.98

0.32

2.25

3.99

4.98

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Short-Term Debt	Get a 7-Day Free Trial															4.80	4.98	5.15	5.23	5.41

Pathfinder Cell Therapy Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Pathfinder Cell Therapy Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines